[{"arm_notes": "", "treatment_id": null, "treatment_name": "VPM1002; a genetically modified BCG vaccine; is being developed with an aim to replace older generation BCG vaccines through demonstrating an improved safety profile and superior efficacy. Participants will receive a single 0.1 mL intradermal injection by an investigator; research nurse or doctor that contains VPM1002; live; 2-8 x 10^5 CFU", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "1", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "1", "treatment_id": 186, "treatment_name": "Bcg vaccine", "treatment_type": "Non covid vaccine", "pharmacological_treatment": "Non covid vaccine"}]